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444Objective: For recalcitrant cervical esophagogastric anastomotic strictures after transhiatal esophagectomy,
a protocol of self-dilatation was developed at the University of Michigan Medical Center, as previously de-
scribed. This study was undertaken to determine the outcomes of this treatment.
Methods: Self-dilatation was required in 158 (7.6%) of 2075 patients with cervical esophagogastric anasto-
motic strictures after transhiatal esophagectomy. An esophageal-specific survey evaluated the frequency and du-
ration of dilatation, swallowing function, and satisfaction with treatment. The relationship among anastomotic
leak, subsequent stricture, and the need for self-dilatation was assessed. Avalidated survey tool, the Short Form
36-item, version 2, was used to assess quality of life.
Results:At the time of this study, 78 of 158 patients were alive; 34 (43%) participated in the esophageal-specific
survey. Median duration of self-dilatation was 10 years. The majority were satisfied with their ability to eat. No
adverse events were reported. All patients said they would use self-dilatation therapy again under similar cir-
cumstances. Of these patients, 20 (59%) responded to the Short Form 36-item, version 2. Compared with the
general population, 55% and 70% of participants scored at or above the norm for physical health and mental
health status, respectively. Patients who required self-dilatation were twice as likely to have a history of cervical
esophagogastric anastomotic leak as those who did not require this therapy (P ¼ .0002).
Conclusions: Refractory cervical esophagogastric anastomotic strictures are best managed initially with
frequent outpatient dilatations, then transitioning to self-dilatation. Home use of Maloney dilators is a safe,
well-tolerated, convenient, and cost-effective way to maintain comfortable swallowing. The effectiveness
of self-dilatation therapy is reflected in this cohort’s good quality of life and level of functioning. (J Thorac Car-
diovasc Surg 2011;141:444-8)Most cases of dysphagia after a transhiatal esophagectomy
(THE) and cervical esophagogastric anastomosis (CEGA)
respond to an occasional esophageal dilatation in the outpa-
tient setting. For more recalcitrant CEGA strictures, a stan-
dardized therapeutic protocol has been developed that
consists of instruction in and implementation of self-
dilatation with a Maloney dilator, as previously described.1
Self-dilatation allows patients to maintain comfortable
swallowing without the need for repeated trips to the doctor.
In addition, the price of a bougie ranges between $100 and
$300, which is a fraction of the cost ofmultiple visits to a tho-
racic surgeon or gastroenterologist for dilatations. During thee University of Michigan Medical School,a University of Michigan Compre-
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The Journal of Thoracic and Cardiovascular Surgpast 3 decades, many patients with refractory strictures have
been managed with this protocol at the University of Michi-
gan Medical Center. However, the efficacy of this program
has not been evaluated systematically. This study was under-
taken to more objectively define the outcomes of this treat-
ment.MATERIALS AND METHODS
This study was approved by the University of Michigan Institutional
Review Board.
Patient Selection
An esophageal resection database of patients treated at the University of
Michigan between 1976 and 2009 was reviewed. From this cohort, 2075
patients who underwent THE and CEGA were identified. Billing records
were used to identify 158 patients who had been issued dilators for home
use. The demographics of this group were compared with the larger cohort
of patients who had undergone THE and CEGA (Table 1). The Social
Security Death Index and electronicmedical records were reviewed to eval-
uate survival status. Eligible candidates were contacted by mail and asked
to return a postcard if interested in taking part in the surveys. Patients who
elected to participate were contacted by phone to conduct the esophageal-
specific survey (ESS) at 1 time point and were later called to follow up with
the Short Form 36-item, version 2 (SF-36v2) survey.
Esophageal-Specific Survey
A survey was developed to characterize home use of theMaloney dilator
and focus on quality of life (QOL) issues related to swallowing. The ESSery c February 2011
Abbreviations and Acronyms
CEGA ¼ cervical esophagogastric anastomosis
ESS ¼ Esophageal-Specific Survey
QOL ¼ quality of life
SF-36v2 ¼ Short Form 36-item, version 2
THE ¼ transhiatal esophagectomy
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use, dysphagia, patient satisfaction, and insurance coverage for the dilator.
Questions about dilator use include whether or not the patients were still
using self-dilatation therapy, the frequency with which they were passing
the dilator, whether or not someone assisted them (eg, friend, significant
other), and if theywere no longer passing the dilator, why they had stopped.
They were asked about difficulty swallowing and whether or not they could
eat what they wanted. Satisfaction with their ability to eat was rated on
a scale of 1 to 5, with 1 being very dissatisfied, 3 being neutral, and 5 being
very satisfied. Patients were asked whether or not they would use self-
dilatation again given similar circumstances and if their insurance provider
covered the cost of the dilator (Figure 1).
Quality of Life Survey
The SF-36v2 questionnaire was used to assess overall QOL. The
SF-36v2 is a well-described QOL measurement tool that has been validated
in multiple patient populations, including patients who have undergone
esophagectomy.2-4 Patients were asked 36 questions about their perceived
physical and mental health status. Physical health is subdivided into
physical functioning, role-physical, bodily pain, and general health compo-
nents. These components are summarized by the physical component
summary score. Mental health is subdivided into social functioning, role-
emotional, vitality, and mental health, which are summarized by the mental
component summary score (Table 2).
Statistical Analysis
Anastomotic leak rates, chemotherapy/radiation therapy, and other de-
mographic variables were compared using a chi-square test. Mean ages
at diagnosis were compared using an independent-samples t test. Median
duration of self-dilatation was calculated using the Kaplan–Meier method.
One-sample t test was used to compare the sample means of SF-36 scores
with the corresponding healthy population means. All statistical analyses
were performed using SPSS or PASW Statistics software (SPSS Inc,
Chicago, IL).RESULTS
Of 2075 patients who underwent THE and CEGA
between 1976 and 2009, 8% (158) were taught self-TABLE 1. Demographic variables
Study population characteristic Self-dilatation (n ¼ 158)
Mean age 59.4  11.8 y
Male gender 73.4% (116)
Caucasian race 96.2% (152)
Malignancy 74.7% (118)
Anastomotic leak 21.5% (34)
Neoadjuvant chemotherapy or RT 57.6% (68)
Postoperative chemotherapy or RT 14.4% (17)
RT, Radiation therapy.
The Journal of Thoracic and Cadilatation therapy at some point in the course of their
follow-up care. Most demographic characteristics of these
patients did not differ significantly from those of patients
who underwent THE and CEGA but did not require self-
dilatation therapy. However, the rate of anastomotic leak
and the use of neoadjuvant chemotherapy or radiation ther-
apy were significantly higher in the self-dilatation cohort
(Table 1). The Maloney dilator size most commonly used
was 46F, because this size most often provides normal or
near normal swallowing in adults. Of these patients,
21.5% had a history of a postoperative CEGA leak. In con-
trast, only 12% of patients who underwent THE who did
not require self-dilatation therapy had a history of CEGA
leak (P ¼ .0002). When this study was initiated, 78 of
158 patients (49%) were alive, and 34 patients (43%)
participated in the ESS. The mean age at the time
self-dilatation therapy was initiated was 58 years (range
40–80 years). The mean duration of follow-up since surgery
was 118 months. The most common indications for
esophagectomy in this cohort were adenocarcinoma (22),
Barrett’s mucosa with high-grade dysplasia (5), and squa-
mous cell carcinoma (3). Other indications included achala-
sia, recurrent hiatal hernia, and caustic injury (4). Fourteen
patients (41%) had a history of neoadjuvant chemotherapy
or radiation.
The median duration of self-dilatation therapy was ap-
proximately 10 years (116 months). The median durations
for the 25th and 75th percentiles were 19 and 60 months, re-
spectively. This result excludes data from 2 patients who
could not recall when they stopped using self-dilatation.
At the time the ESS was conducted, 18 patients (53%)
were still passing their dilator with an average frequency
of once every 64 days. Fourteen patients stopped using their
dilator because it was no longer needed, and 2 patients
stopped at a physician’s request because of a perceived po-
tential for harm. Although 22 patients (65%) reported some
dysphagia, 29 (85%) were satisfied or very satisfied with
their overall ability to eat. The frequency of dysphagia
was difficult for most patients to quantify, and it was usually
reported as occurring only with consumption of particular
foods (ie, bread and meat). There were no reported adverse
events from self-dilatation, and all patients surveyed indi-
cated they would use self-dilatation therapy again underNo self-dilatation (n ¼ 1917) P value
61.6  12.7 y .04
76.6% (1468) .37
94.9% (1819) .47
77.8% (1492) .36
11.5% (221) <.001
42.4% (633) .001
15.0% (224) .86
rdiovascular Surgery c Volume 141, Number 2 445
ESS Question Response
Are you still using your dilator? Yes/No
- If yes, how often? Write-in
- If no, when & why did you stop? Write-in
- If no, how often were you passing the dilator when you 
stopped? Write-in
Have you had any problems related to your self-dilatation therapy? Yes/No
Did anyone assist you? Yes/No
Did you have to be issued >1 size? Yes/No
Any difficulty swallowing currently? Yes/No
- If yes, how often? Rarely – Occasionally – Often – Daily
Does food sometimes “stick”? Yes/No
- If yes, how often? Rarely – Occasionally – Often – Daily
Do you currently have any acid regurgitation/heartburn? Yes/No
Do you sleep with your head elevated? Yes/No
Are you able to eat what you want? Yes/No
- If no, please explain. Write-in
How satisfied  are  you with your ability to eat? Very Satisfied – Satisfied – Neutral –Dissatisfied – Very Dissatisfied
Are you pleased with the results of self-dilatation therapy? Yes/No
Are you better now than before you started self-dilatations? Yes/No
Under similar circumstances, would you use this therapy again? Yes/No
Did insurance pay for the dilator? Yes/No
Did you pay for any part of the cost of the dilator out-of-pocket? Yes/No
- If yes, what portion? Less than 50% – 50% – More than 50% - All
FIGURE 1. The ESS, which assesses dilatation frequency, patient satisfaction, dysphagia, and insurance coverage for self-dilatation therapy. ESS,
Esophageal-Specific Survey.
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Ssimilar circumstances. Health insurance providers covered
at least some of the cost of the dilator in two thirds of cases
(23/34).
Of the 34 patients who responded to the ESS, the majority
(59%) completed the SF-36v2 at a later date. Compared
with a normal, healthy population, 55% of participants
scored at or above the mean for physical health status
(Figure 2). The physical component summary score encom-
passes evaluation of physical functioning, bodily pain, role-
physical, and general health. For mental health status, 70%
of responders scored at or above the mean for healthy con-
trols (Figure 3). The mental component summary assesses
for vitality, social functioning, role-emotional, and mental
health. Therewere no significant differences in mental com-446 The Journal of Thoracic and Cardiovascular Surgponent summary, role-emotional, or mental health mean
scores for our patient population compared with the general
healthy population (Table 2). Most notable physical limita-
tions reported were caused by disease states unrelated to
their esophagectomy or use of self-dilatation therapy.
DISCUSSION
A CEGA stricture is a relatively common cause of dys-
phagia after THE, although cervical dysphagia of varying
degrees may certainly occur in the absence of an identifiable
fibrotic stenosis. There are several methods of esophageal
dilatation, including the use of mercury- or tungsten-
weighted bougies (eg, Maloney dilators), balloon dilators,
or fluoroscopic and wire-guided bougies. Blind passage ofery c February 2011
TABLE 2. Quality of life scores: Results of the Short Form 36-item,
version 2 survey
SF-36v2 components
Study population
mean scores
Healthy population
mean scores
Physical component summary 45.4 55.3*
Physical functioning 44.5 54.8*
Role-physical 46.0 54.4*
Bodily pain 46.4 55.6*
General health 49.1 55.4*
Mental component summary 50.3 53.0
Vitality 49.4 54.6*
Social functioning 47.9 53.8*
Role-emotional 47.3 53.5
Mental health 50.0 53.4
SF-36v2, Short Form 36-item, version 2. *P<.05 (healthy population mean is signif-
icantly higher than sample mean).
FIGURE 3. Percentage of patients with mental component summary
scores above, at, or below the general healthy population mean score.
The mental component summary encompasses evaluation of vitality, social
functioning, role-emotional, and mental health. QOL, Quality of life;
CEGA, cervical esophagogastric anastomosis; SF-36v2, Short Form 36-
item, version 2.
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Sa Maloney dilator is the simplest and most convenient of
these methods, because it can be performed without the
use of sedation, the need for postoperative recovery, or ex-
posure to radiation. When refractory strictures that require
frequent dilatations develop in patients, safety and ease of
use are more important than ever. Home use of Maloney
bougienage offers a method of managing strictures that is
more convenient yet.
When patients report any degree of dysphagia after con-
struction of a CEGA, they undergo an anastomotic dilata-
tion with Maloney esophageal bougies passed without the
use of sedation, generally using 36F, 40F, and 46F dilators.FIGURE 2. Percentage of patients with physical component summary
scores above, at, or below the general healthy population mean score.
The physical component summary encompasses evaluation of physical
functioning, bodily pain, role-physical, and general health. QOL, Quality
of life; CEGA, cervical esophagogastric anastomosis; SF-36v2, Short
Form 36-item, version 2.
The Journal of Thoracic and CaIf there is no resistance to the passage of the dilators, pa-
tients are instructed to return for a follow-up dilatation if
their dysphagia recurs. If there is resistance encountered
with passage of the 46F dilator, or if dysphagia recurs
within several weeks of the dilatation, a stricture is pre-
sumed to be present on clinical grounds. If a 28F dilator
cannot be passed blindly through the anastomosis, endo-
scopic wire-guided dilatation is performed, and the patient
returns to the clinic for follow-up Maloney dilatations
within 1 week.
When multiple clinic visits for dilatations are required,
or when the interval of relief between dilatations is only
days or weeks, the stricture is deemed refractory, and
self-dilatation is considered. In patients presenting with
anastomotic strictures 9 to 12 months or more after an
esophagectomy for cancer, the possibility of a malignant
stricture must be considered, and endoscopy with brushings
for cytology and biopsy should be performed before initiat-
ing dilatation therapy.
After determining that a patient is an appropriate candi-
date for self-dilatation, he or she undergoes biweekly
instructional sessions over 2 to 3 weeks with a caregiver
present. When the patient has demonstrated competency
in performing self-dilatation, a 46F Maloney dilator is
issued for home use. The patient is instructed to pass the
dilator daily for the first week, every other day for the sec-
ond week, and then at increasingly longer intervals until the
longest duration between dilatations without recurrence of
dysphagia is determined.rdiovascular Surgery c Volume 141, Number 2 447
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techniques had comparable safety profiles. This study sug-
gested an algorithm for management of refractory stric-
tures in which self-dilatation was a last resort and an
alternative to surgery.5 The reluctance to prescribe at-
home dilatation seems to be largely due to fear regarding
patient discomfort and risk of perforation in an unsuper-
vised setting. However, neoplastic or inflammatory distal
esophageal stenoses, which may be perforated with Malo-
ney dilatation,6 contrast considerably with fibrotic CEGA
strictures, which have substantially more structural integ-
rity. Our data suggest that patients prefer self-dilatation,
with 85% being overall satisfied with their ability to eat
and all indicating that they would use self-dilatation again
if faced with similar circumstances. Revision of an esoph-
ageal anastomotic stricture may result in additional anasto-
motic scarring and recurrent dysphagia and is not,
therefore, our recommended approach. In fact, anastomotic
revision has only been used in 5 of 2075 patients who un-
derwent THE and CEGA.
CONCLUSIONS
Deciding who will benefit from self-dilatation and when
it should be used can be difficult. Among our 2075 patients,
a CEGA leak developed in 11.5% in the postoperative
period (Table 1). In recent years, this rate has decreased be-
cause of the use of our stapled anastomotic technique.7 Al-
though this complication is easily managed by opening the
neck incision at the bedside, it seems to double the likeli-
hood that a refractory stricture will develop later. It has
long been our practice to pass up to a 46F Maloney dilator
before discharge in any patient experiencing a postoperative
CEGA leak after THE, which serves both to prevent early448 The Journal of Thoracic and Cardiovascular Surganastomotic narrowing and to familiarize the patient with
the procedure. Thoracic surgeons should anticipate that pa-
tients with a CEGA leak will likely require dilatations at
some point, and they should consider discussing self-
dilatation with these patients early on. In addition, the ma-
jority (62%) of patients surveyed required assistance from
a caregiver to pass the dilator, at least initially. Patients
who have an unstable social situation or difficulty compre-
hending the dilatation teaching may not be good candidates
for this type of therapeutic intervention. The results of our
study show that for properly selected candidates, there
should be no hesitancy in initiating self-dilatation therapy
because of reservations regarding its safety or any perceived
negative effects on QOL. Ready access to a full range of
sizes of Maloney esophageal dilators and an established
process for issuing them for home use should be part of
the esophageal surgeon’s armamentarium.References
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